Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs
Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion Shares of Array BioPharma Inc. surged 60 percent
About Array BioPharma Inc. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Array drugs are currently advancing in registration studies:
Array BioPharma Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of targeted small-molecule drugs to treat
Get all latest breaking news on Array Biopharma Inc. Watch videos, top stories and articles on Array Biopharma Inc at moneycontrol.com.
BOULDER, Colo, J /PRNewswire/ - Array BioPharma Inc. ( Array ) today announced that, in connection with the closing of the merger (the Merger ) contemplated by the Agreement and
Tony Piscopio describes the year that Boulder-based Array BioPharma Inc. was acquired by Pfizer Inc. (NYSE: PFE) as transformative for the
BOULDER, Colo, Ap /PRNewswire/ - Array BioPharma Inc.
NEW YORK-(BUSINESS WIRE)- Pfizer Inc. (NYSE:PFE) today announced the successful completion of its acquisition of Array BioPharma Inc
Comments